Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q3 2018 · 10-Q
Revenue$84.00K$84.00K−35.4% vs Q3 2017 Net Income-$3.54M-$3.54MN/M vs Q3 2017 EPS Diluted-$0.83-$0.83N/M vs Q3 2017 Operating Income-$3,570,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,014,000N/M Margins · derivedOperating margin-4250.0%−1912.3 pt vs Q3 2017
Net margin-4219.0%−1910.6 pt vs Q3 2017
ended Sep 30, 2018 · filed Nov 8, 2018 · 39 d after period end